Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2213140120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Jingyi Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Cell Biology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA 02118. Hauptthemen laut MEDLINE: Heterotrimeric GTP-Binding Proteins, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Activation of heterotrimeric G-proteins (Gαβγ) by G-protein-coupled receptors (GPCRs) is a quintessential mechanism of cell signaling widely targeted by clinically approved drugs. However, it has become evident that heterotrimeric G-proteins can also be activated via GPCR-independent mechanisms that remain untapped as pharmacological targets. GIV/Girdin has emerged as a prototypical non-GPCR activator of G proteins that promotes cancer metastasis. Here, we introduce IGGi-11, a first-in-class small-molecule inhibitor of noncanonical activation of heterotrimeric G-protein signaling. IGGi-11 binding to G-protein α-subunits (Gαi) specifically disrupted their engagement with GIV/Girdin, thereby blocking noncanonical G-protein signaling in tumor cells and inhibiting proinvasive traits of metastatic cancer cells. In contrast, IGGi-11 did not interfere with canonical G-protein signaling mechanisms triggered by GPCRs. By revealing that small molecules can selectively disable noncanonical mechanisms of G-protein activation dysregulated in disease, these findings warrant the exploration of therapeutic modalities in G-protein signaling that go beyond targeting GPCRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Cell Biology, Boston University, Chobanian & Avedisian School of Medicine, Boston, MA 02118.
- Centro de Investigaciones Biológicas-Centro Superior de Investigaciones Cientificas, Madrid, Spain.
- Department of Chemistry, Boston University, College of Arts & Sciences, Boston, MA 02115.
- German Center for Neurodegenerative Diseases, Göttingen, Germany.
- Department of Biology, College of Arts & Sciences, Boston University, Boston, MA 02115.
ORCID-Profile: Jingyi Zhao, Mariola Ferreras-Gutierrez, Alain Ibáñez de Opakua, Francisco J Blanco, Mikel Garcia-Marcos
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- NIH HHS
- HHS | National Institutes of Health
- Karin Grunebaum Cancer Research Foundation
- Dahod International Scholar Award
- MEC | Spanish National Plan for Scientific and Technical Research and Innovation
Zitieren
APA
Zhao, J., DiGiacomo, V., Ferreras-Gutierrez, M., Dastjerdi, S., Ibáñez de Opakua, A., Park, J. C., Luebbers, A., Chen, Q., Beeler, A., Blanco, F. J., & Garcia-Marcos, M. (2023). Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2213140120
Vancouver
Zhao J, DiGiacomo V, Ferreras-Gutierrez M, Dastjerdi S, Ibáñez de Opakua A, Park JC, et al. Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2213140120
BibTeX
@article{Zhao2023,
author = {Zhao, Jingyi and DiGiacomo, Vincent and Ferreras-Gutierrez, Mariola and Dastjerdi, Shiva and Ibáñez de Opakua, Alain and Park, Jong-Chan and Luebbers, Alex and Chen, Qingyan and Beeler, Aaron and Blanco, Francisco J and Garcia-Marcos, Mikel},
title = {Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2213140120}
}
EUVIMED